We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$894M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$29.8B
$36.5M 0.23%
115,830
+18,833
+19% +$5.67M
EMR icon
77
Emerson Electric
EMR
$86.7B
$35.1M 0.22%
529,510
-64,136
-11% -$4.31M
LYB icon
78
LyondellBasell Industries
LYB
$19.6B
$35M 0.22%
358,192
+39,635
+12% +$3.77M
CAT icon
79
Caterpillar
CAT
$382B
$33.8M 0.21%
310,752
-18,036
-5% -$1.89M
SLB icon
80
SLB Ltd
SLB
$73.2B
$33.7M 0.21%
285,725
+9,628
+3% +$992K
KMP
81
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$33.6M 0.21%
408,146
+16,394
+4% +$1.27M
DIS icon
82
Walt Disney
DIS
$170B
$33.5M 0.21%
391,079
+36,452
+10% +$2.98M
CVS icon
83
CVS Health
CVS
$134B
$32.8M 0.2%
434,670
+14,392
+3% +$1.09M
BCE icon
84
BCE
BCE
$20.3B
$32.6M 0.2%
717,926
+53,332
+8% +$2.4M
IBM icon
85
IBM
IBM
$213B
$32.1M 0.2%
185,433
-2,343
-1% -$422K
DD
86
DELISTED
Du Pont De Nemours E I
DD
$32M 0.2%
514,202
+15,582
+3% +$1M
F icon
87
Ford
F
$57.5B
$31.9M 0.2%
1,849,163
+42,153
+2% +$686K
DD icon
88
DuPont de Nemours
DD
$19.1B
$31.8M 0.2%
244,319
+15,398
+7% +$1.96M
WU icon
89
Western Union
WU
$2.04B
$31.3M 0.19%
1,803,113
+121,232
+7% +$1.96M
AMLP icon
90
Alerian MLP ETF
AMLP
$13B
$31M 0.19%
326,686
-12,237
-4% -$1.11M
RCI icon
91
Rogers Communications
RCI
$18.4B
$30.9M 0.19%
768,326
+55,914
+8% +$2.26M
NGLS
92
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$30.6M 0.19%
426,140
+10,312
+2% +$667K
NSC icon
93
Norfolk Southern
NSC
$75.6B
$30.4M 0.19%
294,978
-6,830
-2% -$670K
PAA icon
94
Plains All American Pipeline
PAA
$17.1B
$30.3M 0.19%
504,114
+18,996
+4% +$1.08M
BA icon
95
Boeing
BA
$185B
$30.2M 0.19%
237,264
+16,816
+8% +$2.2M
STX icon
96
Seagate
STX
$189B
$29.8M 0.18%
524,277
+71,252
+16% +$3.84M
QQEW icon
97
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.77B
$29.8M 0.18%
763,546
+19,705
+3% +$734K
USB icon
98
US Bancorp
USB
$99.6B
$29.7M 0.18%
685,076
+49,917
+8% +$2.08M
KDP icon
99
Keurig Dr Pepper
KDP
$42.1B
$29.6M 0.18%
504,940
+5,934
+1% +$333K
MCHP icon
100
Microchip Technology
MCHP
$40.8B
$29.5M 0.18%
1,206,796
+118,454
+11% +$2.82M

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $894M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.